Andrew Sandford's Email Addresses & Phone Numbers

Founder @ CSK Foundation Foundation established to raise money and awareness for brain disease. From 1997 to 1997 (less than a year) Technical Service/Sales/ Area Manager - Water Treatement/Biocides @ GE - Power and Water Division (former GRACE/BETZDearborn) Division offering technologies and services to protect high-value assets, maximize run times, reduce maintenance and save energy. From 1992...

Founder @ CSK Foundation Foundation established to raise money and awareness for brain disease. From 1997 to 1997 (less than a year) Technical Service/Sales/ Area Manager - Water Treatement/Biocides @ GE - Power and Water Division (former GRACE/BETZDearborn) Division offering technologies and services to protect high-value assets, maximize run times, reduce maintenance and save energy. From 1992 to October 1996 (4 years) Director of Business Development @ Lonza Division provides services to the biopharmaceutical market place for the development and manufacture of biologic products. Supported transactional and strategic initiatives during transitional period. From June 2005 to April 2007 (1 year 11 months) Dow @ Dow From 1996 to July 2005 (9 years) Greater Boston AreaDow Ventures Sr. New Bus. Dev. Specialists/Platform Leader @ Dow Led (internal) venture funded business building initiatives across multiple industrial markets including - medical devices, drug discovery, biologics manufacturing and consumer products. From 1999 to 2002 (3 years) Greater Boston AreaCommercial Manager - North America @ Dow Responsible for sales forecasting, S&OP leadership, customer management, pricing and new sales.Customers included: J&J, Smith and Nephew, Kendall Corporation, W.L. Gore, 3M, and others. From 1998 to 1999 (1 year) CEO and Co-Founder @ VRex Therapeutics, Inc. Based on the ground-breaking science from the lab of Prof., Dr., Feng Yao at the Brigham and Women's Hospital and Harvard Medical School, we've founded VREX to bring forward the next generation of HSV1 based oncolytic immunotherapies for treatment of solid tumor based cancers. Cambridge, MAStrategic Advisor @ Nirrin Technologies Breakthrough technology in the area of multifaceted online monitoring of critical biologics components enabling the next generation of fully automated bioprocessing. Founder / Co-Managing Director @ Arthropod Biosciences, LLC Intelectual property holding company in support of IP associated with consumer products. Global Vice President, Business Development - Biologics @ Catalent Pharma Solutions Led global business team for Catalent biologics. Member of Catalent's Senior Leadership Team. Member of diligence and M&A teams. Member of Catalent Biologics Scientific Advisory Board. Awarded CEO Growth leader award (multiyear). From January 2014 to January 2020 (6 years 1 month) Greater Boston AreaVice President, Business Development @ Selexis SA Epigenetic gene regulating planform enabling rapid development of stable production cell lines used to produce life saving therapeutics. Established and led global business development. Established and managed US entity (Selexis, Inc.). Executed technology and service based deals with nine figure valuations. From April 2007 to December 2013 (6 years 9 months) Geneva Area, SwitzerlandSr. Business Development Manager // BCMS @ Dow Led global cross-functional team in development and launch of new biotechnology business (Pfenex), NYSE, Ticker PFNX. Corporate Diamond Award Winner for initiative and business building. From March 2002 to June 2005 (3 years 4 months) Boston, Massachusetts, United StatesMarket Development Manager @ Hampsire Chemical (Dow Subsidiary) Unique technology platform enabling over $1B in product sales through value chain. Applications included Gore-Tex(R) (enabling), urethane based hydrogels, advances wound-care dressings, hydrophilic urethane coated catheters, and slow recovery earplugs. Significant product advancements in the medical device, consumer and agricultural markets. From 1996 to 1998 (2 years)